The Society for Integrative Oncology announced new officers and elected four new board members to serve three-year terms at its 2014 annual business meeting on October 28.
Suzanna Zick, ND, MPH from University of Michigan Health System, has become President of SIO, effective at the Society’s International Conference on October 28, 2014. She served as President-Elect for the past year.
Dr. Zick received her degree as a Naturopathic Physician from the National College of Naturopathic Medicine in Portland, Oregon, and her Masters of Public Health in Epidemiology from the University of Michigan in Ann Arbor. Currently, Dr. Zick is a Research Associate Professor in Family Medicine and a Research Associate Professor of Environmental Health Sciences in the School of Public Health at the University of Michigan.
Jun Mao, MD, MSCE, Associate Professor, Department of Family Medicine and Community Health, University of Pennsylvania School of Medicine, was been elected President-Elect of the Society for Integrative Oncology (SIO) at the Society's International Conference on October 28, 2014.
More than 300 physicians, researchers, nurses, integrative medicine practitioners, patient advocates and patients from 17 countries convened at the Omni Galleria in Houston, Texas, from October 26 to 28 at the 11th International Conference of the Society for Integrative Oncology. Programs focused on the theme of personalized integrative oncology - targeted approaches for optimal outcomes. SIO2014 was presented in association with the University of Minnesota Department of Continuing Medical Education and with the assistance of The University of Texas MD Anderson Cancer Center.
SIO2014 featured three outstanding keynote presentations. “The Contributions of Genomics to Integrative Oncology,” presented by John Mendelsohn, MD, past President of MD Anderson Cancer Center, and currently MD Anderson’s Director of the Institute for Personalized Cancer Therapy; the Dr. Rogers Prize Lecture on “Stress and Cancer: From Science to Personal Perspective,” presented by Sonia Lupien, PhD, Fernand-Seguin Research Centre of Louis–H. Lafontain Hospital, Department of Psychiatry at the University of Montreal; and “The Impact of Sleep, Fatigue and Circadian Rhythms on Patients With Cancer,” presented by Sonia Ancoli-Israel, PhD, University of California San Diego School of Medicine.
November 7, 2014 — Over eighty percent of breast cancer patients in the United States use complementary therapies following a breast cancer diagnosis, but there has been little science-based guidance to inform clinicians and patients about their safety and effectiveness. In newly published guidelines from the Society for Integrative Oncology, researchers at Columbia University’s Mailman School of Public Health and the Herbert Irving Comprehensive Cancer Center with colleagues at MD Anderson Cancer Center, University of Michigan, Memorial Sloan Kettering, and other institutions in the U.S. and Canada, analyzed which integrative treatments appear to be most effective and safe for patients. They evaluated more than 80 different therapies.
Meditation, yoga, and relaxation with imagery were found to have the strongest evidence supporting their use. They received an “A” grade and are recommended for routine use for anxiety and other mood disorders common to breast cancer patients. The same practices received a “B” grade for reducing stress, depression, and fatigue, but are also endorsed for most breast cancer patients. Acupuncture received a “B” grade for controlling chemotherapy induced nausea and vomiting and can be recommended to most patients. More than 30 interventions, including some natural products and acupuncture for other conditions, had weaker evidence of benefit due to either small study sizes or conflicting study results, and received a “C” grade. Seven other therapies were deemed unlikely to provide any benefit and are not recommended. One therapy was found to be harmful: acetyl-l-carnitine, which is marketed to prevent chemotherapy-related neuropathy, and actually increased risk for the condition.
SIO President, Dr. Heather Greenlee discusses the landscape of integrative oncology resesarch, including what she envisions is needed for widespread adoption of evidence-based integrative programs.
ALBANY, NEW YORK - More than ever, cancer survivors seek evidence-based information in order to incorporate integrative medicine into conventional cancer care to help improve their outcomes in terms of controlling disease and improving aspects of quality of life in the areas of mind, body and spirit.
The Journal of the National Cancer Institute Monograph has released a special issue entitled “The Role of Integrative Oncology for Cancer Survivorship,” highlighting original research in the field of integrative oncology. This new resource was presented to a global audience of health care professionals and patient advocates in Houston, Texas, at the Eleventh International Conference of the Society for Integrative Oncology, and has been published on line. SIO is an international multi-disciplinary organization established to advance evidence-based, comprehensive integrative health care to improve the lives of people affected by cancer. The articles in the special Monograph were all peer-reviewed.
Omer Kucuk, MD, Professor of Hematology and Medical Oncology and Medical Oncologist at Emory University's Winship Cancer Institute in Atlanta, GA, was elected to the SIO Board of Trustees in October 2013. A board certified and practicing medical oncologist, he is recognized for his pioneering research on nutrition and cancer therapy.
A graduate of Hacettepe University Medical School in Ankara, Turkey, Dr. Kucuk conducted his residency and fellowship at St. Francis Hospital in Evanston, Illinois, and a hematology and oncology fellowship at Northwestern University Medical School in Chicago.
Dear SIO members and friends:
We would very much appreciate you taking a few minutes to take part in an international survey to explore how patient-outcome data is collected within integrative oncology settings worldwide.
As the practice of integrative oncology, in all its forms, becomes an increasingly accepted approach to support people who experience cancer, it is important to efficiently and effectively document patient outcomes, so we can appropriately assess the potential benefits and harms of these approaches.
We are conducting a ‘Delphi consensus’ survey to gather information from as many people involved with integrative oncology programs around the world as possible. We are interested in learning what patient outcome data are currently being collected, which measurement tools are being used, what outcomes are deemed important and what barriers there might be to collecting patient outcome data.
Jun James Mao, MD, MSCE, Associate Professor and Director of Integrative Medicine in the Department of Family Medicine and Community Health at the Perelman School of Medicine at the University of Pennsylvania, was elected to the SIO Board of Trustees at the 2013 SIO Annual Conference in October.
A board certified family physician and licensed physician acupuncturist, Dr. Mao's practice focuses on acupuncture for pain, chronic system distress, and for menopause. He also provides acupuncture and primary care for cancer patients and survivors, integrative medicine for chronic disease and symptom management and integrative medicine to promote wellness. Dr. Mao's expertise in acupuncture and pain management positioned him to become the attending consult physician for the Symptom and Palliative Care Service at the Hospital of the University of Pennsylvania.
At the University of Pennsylvania's Perelman School of Medicine, he directs an international elective on acupuncture for medical students and residents. Over the last five years, this course has attracted more than 200 students from over 50 US institutions.